294 Results

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Miller
    Miller
  4. Rusch
    Rusch
  5. Krug
    Krug
  6. Drilon
    Drilon
  7. Heelan
    Heelan
  8. Azzoli
    Azzoli
  9. Ladanyi
    Ladanyi
  10. Tyson
    Tyson

Groups

  1. Department of Medicine (294)
  2. Solid Tumor Oncology Division (294)
  3. Thoracic Oncology (294)
  4. GSK Faculty (73)
  5. Surgery (70)
  6. Epidemiology and Biostatistics (64)
  7. Biostatistics Service (58)
  8. Human Oncology and Pathogenesis Program (54)
  9. Survivorship Research (51)
  10. Tow Center for Developmental Oncology (TCDO) (50)
  1. "aged"
  2. "Thoracic Oncology"
Formats
  1. Journal Article (289)
  2. Conference Paper (4)
  3. Guidelines (1)
Groups
  1. Department of Medicine (294)
  2. Solid Tumor Oncology Division (294)
  3. Thoracic Oncology (294)
  4. GSK Faculty (73)
  5. Surgery (70)
  6. Epidemiology and Biostatistics (64)

More Groups

People
  1. Mark Kris (173)
  2. Gregory Riely (71)
  3. Vincent Miller (56)
  4. Valerie Rusch (47)
  5. Marc Ladanyi (44)
  6. Lee Krug (35)

More People

Years
  1. 2024 (7)
  2. 2023 (20)
  3. 2022 (13)
  4. 2021 (7)
  5. 2020 (25)
  6. 2019 (14)

More Years

Publications
  1. Clinical Cancer Research (33)
  2. Journal of Thoracic Oncology (30)
  3. Cancer (27)
  4. Journal of Clinical Oncology (19)
  5. Annals of Oncology (11)
  6. New England Journal of Medicine (10)

More Publications

Publishers
  1. Elsevier Inc. (56)
  2. American Association for Cancer Research (37)
  3. Wiley Blackwell (34)
  4. American Society of Clinical Oncology (23)
  5. Springer (21)
  6. Elsevier Science, Inc. (20)

More Publishers

Results (294)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization for detection of MTAP loss in pleural mesothelioma
    Journal Article

    Febres-Aldana, C. A.; Chang, J. C.; Jungbluth, A. A.; Adusumilli, P. S.; Bodd, F. M.; Frosina, D.; Geronimo, J. A.; Hernandez, E.; Irawan, H.; Offin, M. D.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Mesothelioma: Pleural, version 1.2024: Featured updates to the NCCN Guidelines
    Guidelines

    Stevenson, J.; Ettinger, D. S.; Wood, D. E.; Aisner, D. L.; Akerley, W.; Bauman, J. R.; Bharat, A.; Bruno, D. S.; Chang, J. Y.; Chirieac, L. R.; more...
    Journal of the National Comprehensive Cancer Network (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Microsatellite instability and mismatch repair deficiency define a distinct subset of lung cancers characterized by smoking exposure, high tumor mutational burden, and recurrent somatic MLH1 inactivation
    Journal Article

    Yang, S. R.; Gedvilaite, E.; Ptashkin, R.; Chang, J.; Ziegler, J.; Mata, D. A.; Villafania, L. B.; Nafa, K.; Hechtman, J. F.; Benayed, R.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors
    Journal Article

    Patel, S. P.; Alonso-Gordoa, T.; Banerjee, S.; Wang, D.; Naidoo, J.; Standifer, N. E.; Palmer, D. C.; Cheng, L. Y.; Kourtesis, P.; Ascierto, M. L.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma
    Journal Article

    Shin, J. Y.; Offin, M.; Simone, C. B. 2nd; Zhang, Z.; Shepherd, A. F.; Wu, A. J.; Shaverdian, N.; Gelblum, D. Y.; Gomez, D. R.; Sauter, J. L.; more...
    Radiotherapy and Oncology (2024)

    Fulltext@MSK | Save
  • Repotrectinib in ROS1 fusion-positive non-small-cell lung cancer
    Journal Article

    Drilon, A.; Camidge, D. R.; Lin, J. J.; Kim, S. W.; Solomon, B. J.; Dziadziuszko, R.; Besse, B.; Goto, K.; de Langen, A. J.; Wolf, J.; more...
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save
  • Diagnosis, testing, treatment, and outcomes among patients with advanced non-small cell lung cancer in the United States
    Journal Article

    Yang, M.; MacEwan, J. P.; Boppudi, S. S.; McClain, M. R.; O'Hara, R. M. Jr; Paik, P. K.
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Clinical decision support for chemotherapy-induced neutropenia using a hybrid pharmacodynamic/machine learning model
    Journal Article

    Hughes, J. H.; Tong, D. M. H.; Burns, V.; Daly, B.; Razavi, P.; Boelens, J. J.; Goswami, S.; Keizer, R. J.
    CPT: Pharmacometrics and Systems Pharmacology (2023)

    Fulltext@MSK | Save
  • Tepotinib in patients with non-small cell lung cancer with high-level MET amplification detected by liquid biopsy: VISION Cohort B
    Journal Article

    Le, X.; Paz-Ares, L. G.; Van Meerbeeck, J.; Viteri, S.; Galvez, C. C.; Smit, E. F.; Garassino, M.; Veillon, R.; Baz, D. V.; Pradera, J. F.; more...
    Cell Reports Medicine (2023)

    Fulltext@MSK | Save